Case Report: Successful treatment of steroid-refractory immune checkpoint inhibitor associated myocarditis with tofacitinib

The advent of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment but is associated with immune-related adverse events (irAEs) that can involve multiple organ systems.Steroid-refractory immune checkpoint inhibitor associated myocarditis, defined as persistent or progressive myoca...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Defei Kong, Feng Zhang, Yanxia Liu, Xiaojuan Zhu, Ting Yuan, Anli Liu, Lulin Zhou, Wen Chen, Qingmin Yao
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-03-01
Serija:	Frontiers in Immunology
Teme:	immune checkpoint inhibitors immune-related adverse events Janus kinase inhibitors multiple organ injury steroid-refractory immune checkpoint inhibitor associated myocarditis tofacitinib
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1778284/full
Oznake:	Označite Brez oznak, prvi označite!